{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Merk-Ahmad K"],"funding":["Deutsche Forschungsgemeinschaft"],"pagination":["3226"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10296629"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(12)"],"pubmed_abstract":["Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the <i>RHOA</i> mutation G17V in neoplastic cells, which is observed in around 60% of patients. Because <i>RHOA</i> is involved in both T-cell receptor downstream signalling and cell migration, we hypothesized that the characteristic presentation of AITL could be the result of enhanced tumor cell migration. Therefore, this study aimed to elucidate the impact of the RHOA variant G17V on the migration of neoplastic T cells. We transfected the T-cell lymphoma cell lines HH and HuT78 to stably express the RHOA-G17V variant. RHOA-G17V-expressing T cells did "],"journal":["Cancers"],"pubmed_title":["The <i>RHOA</i> Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling."],"pmcid":["PMC10296629"],"funding_grant_id":["HA6145/7-1","HA6145/6-1","HA6145/6-1 and HA6145/7-1"],"pubmed_authors":["Ullrich E","Oellerich T","Flinner N","Schneider O","Donnadieu E","Senff T","Schafer H","Hansmann ML","Haupl B","Bein J","Piel M","Loth AG","Hartmann S","Scharf S","Merk-Ahmad K","Bexte T"],"additional_accession":[]},"is_claimable":false,"name":"The <i>RHOA</i> Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling.","description":"Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (AITL), is characterized by constitutional symptoms, advanced-stage disease, and generalized lymphadenopathy. A genetic hallmark of this lymphoma is the frequent occurrence of the <i>RHOA</i> mutation G17V in neoplastic cells, which is observed in around 60% of patients. Because <i>RHOA</i> is involved in both T-cell receptor downstream signalling and cell migration, we hypothesized that the characteristic presentation of AITL could be the result of enhanced tumor cell migration. Therefore, this study aimed to elucidate the impact of the RHOA variant G17V on the migration of neoplastic T cells. We transfected the T-cell lymphoma cell lines HH and HuT78 to stably express the RHOA-G17V variant. RHOA-G17V-expressing T cells did ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jun","modification":"2026-04-08T13:38:54.741Z","creation":"2024-11-08T10:02:00.57Z"},"accession":"S-EPMC10296629","cross_references":{"pubmed":["37370838"],"doi":["10.3390/cancers15123226"]}}